$SLGN

SILGAN HOLDINGS INC (SLGN): Results of Operations and Financial Condition

SILGAN HOLDINGS INC (SLGN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a991_63026.htm EX-99.1 Document Silgan Holdings Inc. Exhibit 99.1 SILGAN ANNOUNCES SECOND QUARTER 2026 RESULTS H ighlights • Achieved high single digit volume growth in dispensing products for fragrance markets • Delivered high single digit volume growth in metal contai

Original reporting
Published Jul 29, 2026, 8:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 29, 2026, 8:35 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$SLGN
Neutral
medium confidence
Mentioned
$SLGN
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$SLGNNeutralMed
01

Why it matters

The filing gives a fresh quarterly datapoint for revenue, net income, adjusted EPS, and segment EBIT, plus a specific long-term supply agreement execution. It is actionable for positioning around earnings season and for assessing whether volume growth is translating into operating profit.

02

Market read

Q2 2026 shows 7% net sales growth and high single digit volume growth in key franchises, but profitability (net income and EBIT) is lower than Q2 2025, creating a mixed setup for the stock’s reaction.

03

What to watch

Adjusted EPS is higher than reported EPS due to adjustments, so traders should separate underlying operating performance (EBIT down) from non-GAAP adjustments when forming a view.

Relevance 7/10Novelty 7/10Timing: after-hours filing of Q2 2026 results on SEC 8-K

Background

This is an SEC Form 8-K with Exhibit 99.1 reporting Silgan’s second quarter 2026 results and segment performance, including commentary on dispensing, metal containers, and custom containers.

Company-level read

Ticker impact

$SLGNNeutralMedium confidence
Context

Silgan reported Q2 2026 net sales of $1.64B and net income of $75.8M, plus segment volume growth and a new long-term supply agreement.

Expected impact

Near-term bias likely mixed: revenue and volume growth are supportive, but lower net income and EBIT versus prior year may cap upside unless investors focus on adjusted EPS and new business wins.

Evidence & confidence

The filing provides concrete quarterly financials (sales, net income, adjusted EPS) and segment drivers, but it does not include full-year guidance or a clear incremental forecast change beyond qualitative “momentum into the second half.”

Market effects

Rigid packaging demand signals remain constructive in dispensing and pet-food-related metal containers, with pricing pass-through still a key earnings driver.

Brazil volume/mix headwind is explicitly cited for dispensing products, implying regional demand variability within the segment.

Geopolitical and macro uncertainty is referenced, but the disclosed financial drivers are company-specific (pass-through, mix, volume).

Counterpoint

Investors may discount the “strong momentum” language because the revenue increase is largely explained by raw-material cost pass-through, while EBIT and net income declined year over year.

Key entities

  • Silgan Holdings Inc.

    NYSE-listed rigid packaging supplier reporting Q2 2026 financial results and segment performance.

  • NORWALK, CT

    Press release location for the Q2 2026 results announcement.

Related articles

$SLGNMed

Silgan Holdings Inc. Q2 2026 Earnings Call Summary

Strategic Performance Drivers Management attributed Q2 performance to strong execution in high-value segments like fine fragrance and wet pet food, which helped offset geopolitical and inflationary headwinds. Dispensing and Specialty Closures (DSC) faced a 15% volume decline in Brazil due to inflationary market conditions, though management views this as a temporary market dynamic rather than a loss of share.

$SLGNMed

Silgan Q2 Earnings Call Highlights

Fabry said the combination of Brazil volume weakness and less favorable mix reduced second-quarter results by about $5 million. Despite that impact, adjusted EBIT in the segment was comparable with the prior year as favorable price over cost offset the volume and mix pressure. Greenlee highlighted continued strong growth in fine-fragrance dispensing products, particularly in Europe.

$SLGNMed

Silgan Q2 profit slips despite higher sales

Silgan has posted a net income of $75.8m for the second quarter (Q2) of 2026, down from $89m in the same period of 2025. Quarterly sales reached $1.64bn, an increase of $104.1m, or 7%, from a year earlier. Discover B2B Marketing That Performs Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

$SLGNMedAI 8/10

Silgan (SLGN) Q2 2026 Earnings Call Transcript

Silgan (SLGN) held its Q2 2026 earnings call, reporting net sales of about $1.6 billion, up 7% year over year, and adjusted EPS of $0.98. Adjusted EPS was below the prior year due to lower adjusted EBIT. The company confirmed 2026 adjusted EPS guidance of $3.73 to $3.93 and gave Q3 2026 adjusted EPS guidance of $1.21 to $1.31.

$JANMedAI 8/10

JAN Q2 Earnings Call Highlights

Janus Living (NYSE:JAN) reported sequential same-store NOI margin down 40 bps, citing seasonality. Occupancy rose for independent living but fell for skilled nursing. The company acquired two communities for $105M, sold one for $23M, and completed $1B more acquisitions post-quarter. It raised 2026 FFO guidance to $0.95-$0.98 and same-store adjusted NOI growth to 13%-17%.